Evidence map›Paper›PMID 38116039›Full record

ArticleFrontiers in medicine2023

Corrigendum: Absolute oxygen-guided radiation therapy improves tumor control in three preclinical tumor models.

Inna Gertsenshteyn, Boris Epel, Mihai Giurcanu, Eugene Barth, John Lukens, Kayla Hall, Jenipher Flores Martinez, Mellissa Grana, Matthew Maggio, Richard C Miller and 8 more

Abstract readPublished Erratum
In one paragraph

Article in Frontiers in medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. A Practical, Noninvasive Urine Collection Method for Mice for Large Cohort Preclinical Studies.Journal of the American Association for Laboratory Animal Science : JAALAS · 2026
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors.

Inna Gertsenshteyn *Department of Radiation and Cellular Oncology, The University of Chicago, Chicago, IL, United States.
Boris Epel *Department of Radiation and Cellular Oncology, The University of Chicago, Chicago, IL, United States.
Mihai GiurcanuDepartment of Public Health Sciences, The University of Chicago, Chicago, IL, United States.
Eugene BarthDepartment of Radiation and Cellular Oncology, The University of Chicago, Chicago, IL, United States.
John LukensDepartment of Radiation and Cellular Oncology, The University of Chicago, Chicago, IL, United States.
Kayla HallDepartment of Radiation and Cellular Oncology, The University of Chicago, Chicago, IL, United States.
Jenipher Flores MartinezDepartment of Radiation and Cellular Oncology, The University of Chicago, Chicago, IL, United States.
Mellissa GranaDepartment of Radiation and Cellular Oncology, The University of Chicago, Chicago, IL, United States.
Matthew MaggioDepartment of Radiation and Cellular Oncology, The University of Chicago, Chicago, IL, United States.
Richard C MillerDepartment of Radiation and Cellular Oncology, The University of Chicago, Chicago, IL, United States.
Subramanian V SundramoorthyDepartment of Radiation and Cellular Oncology, The University of Chicago, Chicago, IL, United States.
Martyna Krzykawska-SerdaCenter for EPR Imaging in vivo Physiology, The University of Chicago, Chicago, IL, United States.
Erik PearsonDepartment of Radiation and Cellular Oncology, The University of Chicago, Chicago, IL, United States.
Bulent AydoganDepartment of Radiation and Cellular Oncology, The University of Chicago, Chicago, IL, United States.
Ralph R WeichselbaumDepartment of Radiation and Cellular Oncology, The University of Chicago, Chicago, IL, United States.
Victor M TormyshevNovosibirsk Institute of Organic Chemistry, Novosibirsk, Russia.
Mrignayani KotechaO2M Technologies, Chicago, IL, United States.
Howard J HalpernDepartment of Radiation and Cellular Oncology, The University of Chicago, Chicago, IL, United States.

Funding

VIRAL ONCOLOGY CORE FACILITYP30CA014599 · NCI · UNIVERSITY OF CHICAGO · PI KUNLE ODUNSI · 1985 to 2026
$122.1M
Very Low Frequency EPR Imaging in Vivo Phisiology P41 EB02034P41EB002034 · NIBIB · UNIVERSITY OF CHICAGO · PI HALPERN, HOWARD J · 2003 to 2017
$16.1M
RESEARCH TRAINING IN MEDICAL PHYSICST32EB002103 · NIBIB · UNIVERSITY OF CHICAGO · PI ARMATO, SAMUEL G. · 2003 to 2019
$4.7M
Radiation Biology of EPR Oxygen ImagesR01CA098575 · NCI · UNIVERSITY OF CHICAGO · PI HALPERN, HOWARD J · 2003 to 2022
$4.5M
Improved Radiation Therapy of Hypoxic Tumor Regions by Integrated PET, EPR, and MR Imaging - Resubmission 01 - Revision - 1R01CA236385 · NCI · UNIVERSITY OF CHICAGO · PI CHEN, CHIN-TU, HALPERN, HOWARD J · 2020 to 2024
$3.3M
Preclinical Oxygen Imager to Model Efficient Cancer TreatmentR44CA224840 · NCI · O2M TECHNOLOGIES, LLC · PI KOTECHA, MRIGNAYANI · 2019 to 2020
$2.3M
Optimization of Cancer Therapy guided by oxygen, pH, thiol and other parametric imagesR50CA211408 · NCI · UNIVERSITY OF CHICAGO · PI EPEL, BORIS · 2016 to 2020
$637k
Correcting [18]F-Misonidazole PET with MRI and EPR to improve hypoxia-guided radiation therapyF31CA254223 · NCI · UNIVERSITY OF CHICAGO · PI GERTSENSHTEYN, INNA · 2021 to 2021
$46k
NCI NIH HHS F31 CA254223NCI NIH HHS P30 CA014599NCI NIH HHS R01 CA098575NCI NIH HHS R01 CA236385NCI NIH HHS R44 CA224840NCI NIH HHS R50 CA211408NIBIB NIH HHS P41 EB002034NIBIB NIH HHS T32 EB002103
6 · The paper itself

Abstract

[This corrects the article DOI: 10.3389/fmed.2023.1269689.].

Indexed as

electron paramagnetic resonancehypoxiaoxygenpreclinical imagingradiotherapy

Identifiers

PMID38116039
PMCPMC10728871

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.